Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Appointed CFO
Quarterly results
Appointed director
Savara Inc (SVRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
03/12/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "SAVARA REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
08/08/2019 8-K Quarterly results
Docs: "SAVARA REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
05/09/2019 8-K Quarterly results
Docs: "SAVARA REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
03/13/2019 8-K Quarterly results
Docs: "SAVARA REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
11/07/2018 8-K Quarterly results
Docs: "SAVARA REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
08/09/2018 8-K Quarterly results
Docs: "SAVARA REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES POSITIVE BUSINESS UPDATE ● Molgradex Phase 3 IMPALA study enrollment on track for completion in Q3 2018 ● AeroVanc Phase 3 AVAIL study enrollment on track for completion in Q1 2019 ● Molgradex Phase 2a OPTIMA study enrollment on track for completion in Q3 2018; Interim results expected in Q4 2018 ● Molgradex commercialization preparations underway ● Launched exploratory product pipeline ● Conference call scheduled for today at 5:30 p.m. E.T."
05/09/2018 8-K Quarterly results
Docs: "SAVARA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
03/14/2018 8-K Quarterly results
Docs: "SAVARA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
11/08/2017 8-K Quarterly results
Docs: "SAVARA REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - Anticipating complete enrollment in the Molgradex Phase 3 IMPALA study in Q1 2018 - Initiating Phase 2a study of Molgradex for the treatment of NTM in early 2018 - Expecting top-line results from the Aironite Phase 2 INDIE study in H1 2018 - Conference call scheduled for today at 5:30 p.m. E.T."
08/09/2017 8-K Quarterly results
Docs: "SAVARA REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE On track to initiate Phase 3 study of AeroVanc in Q3 2017 On track to complete enrollment of Aironite Phase 2 INDIE study in Q4 2017 On track to complete enrollment in Molgradex Phase 3 IMPALA study in Q1 2018"
03/06/2017 8-K Form 8-K - Current report
11/08/2016 8-K Quarterly results
Docs: "MAST THERAPEUTICS REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS"
08/09/2016 8-K Form 8-K - Current report
05/06/2016 8-K Form 8-K - Current report
03/14/2016 8-K Form 8-K - Current report
11/12/2015 8-K Form 8-K - Current report
08/12/2015 8-K Form 8-K - Current report
05/11/2015 8-K Form 8-K - Current report
03/24/2015 8-K Form 8-K - Current report
10/31/2014 8-K Form 8-K - Current report
08/11/2014 8-K Form 8-K - Current report
05/05/2014 8-K Form 8-K - Current report
03/26/2014 8-K Form 8-K - Current report
11/04/2013 8-K Form 8-K - Current report
08/05/2013 8-K Form 8-K - Current report
05/15/2013 8-K Form 8-K - Current report
03/19/2013 8-K Form 8-K - Current report
11/05/2012 8-K Form 8-K - Current report
08/06/2012 8-K Form 8-K - Current report
05/07/2012 8-K Form 8-K - Current report
03/07/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy